CONTROL OF CELL POLARITY IN C ELEGANS
线虫细胞极性的控制
基本信息
- 批准号:2385164
- 负责人:
- 金额:$ 9.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-08-01 至 2002-07-31
- 项目状态:已结题
- 来源:
- 关键词:Caenorhabditis elegans alleles biological signal transduction cellular polarity cytogenetics developmental genetics fluorescence microscopy gene complementation gene expression gene interaction gene mutation genetic mapping genetic regulation in situ hybridization laboratory rabbit microorganism genetics molecular cloning phenotype protein signal sequence regulatory gene
项目摘要
The long range goal of the proposed research is to understand how
cell polarity is controlled during metazoan development. Genes that
control the cell polarity of individual cells in the nematode C.
elegans will be identified and studied using genetic and molecular
methods. Mutations in one such gene, lin-44, cause the polarity of
certain cells in the tall to be reversed with respect to the body
axis. Lin-44 encodes a WNT protein, is expressed by the skin cells
at the tip of the animal's tail and functions to specify the
polarity of more anterior tall cells. The Wnt gene family encode
secretory glycoproteins that act as short-range signaling molecules
involved in many developmental processes in many different species.
The first member of the Wnt family was isolated as a proto-oncogene
that when activated caused murine breast cancer. One goal of this
work is to understand how a WNT signal from cells in the tip of the
tail influences the polarities of the cells that receive the
signal. Novel genes that interact with C. elegans WNT gene lin-44
to control cell polarity will be identified by identifying
mutations that disrupt the polarities of cells whose polarities are
controlled by lin-44. Preliminary genetic screens have already
identified two such genes, lop-1 and lop- 2. Genetic screens will
also be used to identify mutations that act to suppress the
polarity defects caused by lin-44 mutations. These newly identified
genes might be involved in the production and secretion of LIN-44
signal, the reception and transduction of the signal, or the
execution of the polarity information carried by LIN 44. Genetic
and phenotypic characterization of the two newly identified genes
that function in the control of cell polarity, lop-1 and lop-2 will
be performed. Molecular analysis of lop-l and lop-2 will be
performed to learn what they encode and what roles they play in the
control of cell polarity. LIN-44 antibodies will be generated to
identify the cells that accumulate LIN-44. Comparison of the
protein localization pattern with the localization of lin-44
transcripts will help to determine other cells that secrete LIN-44
as well as cells that receive LIN-44 signal. This information will
be useful in the analysis of new genes that function with lin-44 to
control cell polarity. Several Wnt genes, as well as genes that
have been shown to be components of the WNT signal transduction
pathway, have been implicated in several forms of cancer. The
identification of novel genes that interact with lin-44 to control
cell polarity may also provide insights to WNT signal transduction.
拟议研究的远距离目标是了解如何
细胞极性在后生动物发育过程中受到控制。基因
控制线虫C中单个细胞的细胞极性。
秀丽隐杆线将使用遗传和分子进行鉴定和研究
方法。一个这样的基因的突变lin-44导致极性
高个子中的某些细胞相对于身体逆转
轴。 LIN-44编码Wnt蛋白,由皮肤细胞表达
在动物的尾端和功能上,以指定
更高高细胞的极性。 Wnt基因家族编码
作用于短距离信号分子的分泌糖蛋白
参与许多不同物种的许多发育过程。
Wnt家族的第一个成员被隔离为原始癌基因
激活后会导致鼠乳腺癌。一个目标
工作是了解如何在细胞尖端的细胞信号
尾部影响接收的细胞的极性
信号。与秀丽隐杆线虫相互作用的新型基因Wnt Gene Lin-44
通过识别来控制细胞极性
破坏极性的细胞极性的突变
由LIN-44控制。初步的遗传筛查已经
确定了两个这样的基因,分别是LOP-1和LOP-2。遗传筛选将
也用于识别作用以抑制的突变
LIN-44突变引起的极性缺陷。这些新发现
基因可能参与LIN-44的生产和分泌
信号,信号的接收和转导,或
Lin 44携带的极性信息的执行。遗传
和两个新鉴定的基因的表型表征
该功能在控制细胞极性,LOP-1和LOP-2方面将
被执行。 LOP-L和LOP-2的分子分析将是
表演以了解他们的编码以及他们在
控制细胞极性。 LIN-44抗体将生成
识别积累LIN-44的细胞。比较
蛋白质定位模式与LIN-44的定位
成绩单将有助于确定其他分泌LIN-44的细胞
以及接收LIN-44信号的单元。这些信息将
在分析lin-44的新基因中有用
控制细胞极性。几个Wnt基因以及
已证明是Wnt信号转导的组成部分
途径与几种形式的癌症有关。这
鉴定与Lin-44相互作用以控制的新型基因
细胞极性还可以为WNT信号转导提供见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL A HERMAN其他文献
MICHAEL A HERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL A HERMAN', 18)}}的其他基金
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
- 批准号:32371910
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Exploring the function and shedding of a potential C. elegans Neuregulin
探索潜在的线虫神经调节蛋白的功能和脱落
- 批准号:
10629996 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
Genetic Analyses of Dendrite Morphogenesis in Caenorhabditis Elegans
秀丽隐杆线虫树突形态发生的遗传分析
- 批准号:
10736702 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
SPOP modifies neurodegenerative proteinopathy in Alzheimer’s Disease.
SPOP 可以改善阿尔茨海默病中的神经退行性蛋白病。
- 批准号:
10675938 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
Modeling PIEZO associated diseases in Caenorhabditis elegans: from genetics to mechanism
秀丽隐杆线虫 PIEZO 相关疾病建模:从遗传学到机制
- 批准号:
10866791 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
Cell-Intrinsic Mechanisms of Presynaptic Assembly
突触前组装的细胞内在机制
- 批准号:
10786383 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别: